Altogether, these results indicate that CD8+ T cells from ZIKV-infected mice are capable of antigen-independent killing of YAC-1 tumor cells, and that this cytotoxicity is exacerbated by inflammatory stimuli, such as IL-12/18 treatment. The gene discussed is CD8A; the disease is neoplasm.